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orescence staining and qRT-PCR.
RESULTS After oral administration, aspirin could effectively inhibit
platelet P-selectin (CD62P) expression and the ratio of TXB2 and 6-
keto-PGF1a in control group, but failed to take effect in HFD/STZ-
induced diabetic mice. The SA concentration in HFD/STZ-induced
diabetic mice was still signiﬁcantly higher than that in normal mice.
Immunohistochemical analysis revealed an decreased expression of
COX-2 in the HFD/STZ-induced diabetic mice by the aspirin treatment.
Compared with control group, the mRNA levels for renal OAT1, OAT2
and SMCT1 were unanimously down-regulated in HFD/STZ-induced
diabetic mice, in accordance with the pathological changes of kidney.
CONCLUSIONS Our study reports the novel ﬁnding that SA accumula-
tion ;renders AR via breaking the balance of the innate COX-1/COX-2
function in HFD/STZ-induced diabetic mouse model. The mechanism of
SA accumulation is largely attributed to the down-regulation of renal
transporter function and acidic environment in the diabetic state.
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OBJECTIVES Both the CHADS2 and CHA2DS2-VASc scores are well-
validated for predicting risk of stroke among patients with atrial ﬁbril-
lation (AF), but most validation studies have been in Western
populations. Some uncertainty is evident for the selection of which score
to guide optimal anticoagulant therapy among Asian populations with
AF. We aimed to perform a systemic review and meta-analysis of avail-
able studies to compare CHADS2 and CHA2DS2-VASc scores for risk
stratiﬁcation and second, to establish which score has a better perfor-
mance in identifying ‘truly low risk’ AF patients from Asia.
METHODS A systemic literature search of Cochrane library, Scopus,
and PubMed databases was conducted using search terms including
atrial ﬁbrillation, CHADS2 and CHA2DS2-VASc. Stroke / thromboem-
bolism outcome events at low, moderate, and high risk groups were
compared in relation to both scores. Statistical analyses were per-
formed using Revman 5.3 software.
RESULTS 493 records were retrieved, of which 6 cohort studies focusing
on non-anticoagulated patients from Asian regions were appraised and
included. Absolute event rates were usually lower when patients were
categorized as CHA2DS2-VASc of 0-1, rather than CHADS2 of 0-1, respec-
tively. Meta-analysis revealed that when compared with the CHA2DS2-
VASc score, there was a 1.71-fold (95% conﬁdence intervals (CI): 1.26-2.31)
elevated risk of stroke when patients were stratiﬁed as ‘low risk’ using a
CHADS2 score¼0, or a 1.40-fold (95%CI: 1.20-1.64) increase with a
CHADS2score¼1. A 1.19-fold (95%CI: 1.02-1.38) elevated risk was observed
amongst CHADS2 score 2, but the total number of events were higher
when patients were categorized as CHA2DS2-VASc 2.
CONCLUSIONS The CHA2DS2-VASc score is superior to the CHADS2
score in identifying ‘truly low risk’ Asians patients with AF. Rather
than a categorical (ie. low/moderate/high risk) approach, Asian
guidelines should adopt a 2 step approach, by initially identifying the
low risk patients (using the CHA2DS2-VASc score) who do not need any
thromboprophylaxis, following which effective stroke prevention can
be offered to those with 1 stroke risk factors.
GW26-e1022
Prognostic importance of C-reactive protein in acute myocardial
infarction: A systematic review and meta-analysis of prospective studies
Jiayu Diao, Jin Wei
Department of Cardiology, The Second Afﬁliated Hospital of Xi’an
Jiaotong University
OBJECTIVES It was controversial that whether C-reactive protein
(CRP) was a prognostic marker in patients with acute myocardial
infarction (AMI). We undertook this meta-analysis to make it clear.
METHODS A systematic literature search was conducted using Med-
line, PubMed, and Web of Science for prospective studies of patientswith AMI that reported outcomes according to serum CRP levels. The
relationships between levels of CRP and prognoses were assessed.
RESULTS 10368 patients in 9 studies were identiﬁed. Long term
follow-up varied from 6 months to 10 years. Mean level of CRP was
8.79mg/L. High CRP levels were associated with higher mortality(odds
ratio, 2.40; 95% CI, 1.44 to 3.99; P<0.001) and more heart failure (odds
ratio, 2.08; 95% CI, 1.49 to 2.89; P<0.001). The risk of mortality
remained evident in subgroup analyses according to cut-off level of
CRP. For the cut-off level of 3 mg/L and 10mg/L, the odds ratios of
mortality were 2.69 (95% CI, 1.06 to 6.82, P ¼ 0.04) and 2.32 (95% CI,
1.18 to 4.55, P¼0.01), respectively.
CONCLUSIONS A high level of serum CRP was signiﬁcantly associated
with poor prognoses in patients with AMI.
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OBJECTIVES Cardiovascular autonomic neuropathy (CAN) is closely
associated with increased mortality in diabetic patients. Several risk
factors of CAN have been clearly clariﬁed. However, the impact of
cystatin C(Cys C) on CAN is still unclear. Therefore, this study aimed
to investigate the association between Cys C and CAN in newly
diagnosed type 2 diabetic patients with normal renal function and
urinary albumin excretion rate (UAER).
METHODS 90 newly diagnosed type 2 diabetic patients (58%male, mean
age: 48 years old) were enrolled. Heart rate variability (HRV) measured
by Holter were used to identify CAN. Cys C was measured by particle-
enhanced turbidimetric immunoassay (PETIA). Based on the results from
HRV, subjects were then further divided into two groups: diabetic pa-
tients with CAN (CANþ group) or without CAN (CAN- group).
RESULTS The positive rate of CAN in newly diagnosed type 2 diabetic
patients was 35.6%. Compared with CAN- group (n ¼58), CANþ group
(n ¼32) had signiﬁcantly higher Cys C (0.97 0.32 vs. 0.75  0.14 mg/L,
P¼0.02) but no signiﬁcant differences were observed in creatine, glycated
hemoglobin (HbA1c) or UAER between groups. Cys C was correlated with
SDNNINDEX (r ¼-0.38, P ¼0.04), Low frequency domain(LF) (r ¼-0.48,
P ¼0.008) and Highfrequency domain(HF) (r ¼-0.49, P ¼0.006). Logistic
regression analysis revealed that Cys C was an independent risk factor of
CAN in this population (OR:1.71, 95%CI:1.57w1.87, P ¼0.037) after
adjusting for creatine, HbA1c and systolic blood pressure.
CONCLUSIONS Prevalence of cardiovascular autonomic nerve is high
in newly diagnosed type 2 diabetic patients with normal renal func-
tion and UAER. Cys C is associated with CAN in this population.
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OBJECTIVES Oral anticoagulation (OAC, eg. warfarin) is effective for
stroke prevention in patients with atrial ﬁbrillation (AF), but underuse
of warfarin is common, and data on clinical features associated with
non-use in Asian countries are limited. The present study was per-
formed to provide insights into ‘real world’ OAC use in hospitalized
nonvalvular AF patients in the Nanchang AF Project.
METHODS We studied consecutive non-valvular AF patients admitted
to cardiovascular department in the second afﬁliated hospital of
Nanchang University between May 2011 and December 2013. Antith-
rombotic therapy use among AF patients were analyzed in relation to
age groups (<40 years, 40-64 years, 65-74 years, 75 years), and
CHA2DS2-VASc score strata (low risk (0 for male or 1 for female), 1 for
male, high risk ie. 2). Multivariate regression analysis was conducted
to evaluate the predictors of warfarin use.
RESULTS Among the 1453 NVAF patients, warfarin use before admission
was extremely low (9.4%) and increased to 44.7% during hospitalization.
The proportions of patients on warfarin decreased with age across the four
